Welcome to PillPicks! The blog includes three separate sources of information to assist in your investing goals. PillPicks Stock InformationPillPicks provides a technical analysis of pharmaceutical companies at the time of the post, providing insight on support, resistances, and overall direction. In addition, PillPicks analyzes the clinical data and published literature for the pharmaceutical products. … Continue reading Welcome to PillPicks!
Welcome to part three of Non-Pharm Finance. Within this section, we discuss how to start investing by recommending where to put your money and how to diversify your portfolio.
Defining Mutual Funds, Index Funds, Exchange-Traded Funds, and Leveraged Exchange Traded Funds for New Traders
Alnylam Pharmaceuticals, Inc. is focused on the discovery, development and commercialization of RNA interference therapeutics. They currently have an approved product, ONPATTRO (patisaran), and multiple pipeline products. The company currently appears to be a good swing trade. Click to read more about my technical analysis and their siRNA technology
Seattle Genetics is an attractive short term swing trade. The company currently has an approved product, ADCETRIS® (brentuximab vedotin), and focuses on antibody-drug conjugate technology. Click to read more about my technical analysis and ADC technology.